These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 3406919)

  • 1. Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern.
    Newman SP; Woodman G; Clarke SW
    Thorax; 1988 Apr; 43(4):318-22. PubMed ID: 3406919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choice of nebulisers and compressors for delivery of carbenicillin aerosol.
    Newman SP; Pellow PG; Clarke SW
    Eur J Respir Dis; 1986 Sep; 69(3):160-8. PubMed ID: 3780896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebuliser systems for drug delivery in cystic fibrosis.
    Daniels T; Mills N; Whitaker P
    Cochrane Database Syst Rev; 2013 Apr; (4):CD007639. PubMed ID: 23633344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulmonary deposition of colistin aerosols in cystic fibrosis. Comparison of an ultrasonic nebulizer and a pneumatic nebulizer].
    Gagnadoux F; Diot P; Marchand S; Thompson R; Dieckman K; Lemarié E; Varaigne F; Maurage C; Baulieu JL; Rolland JC
    Rev Mal Respir; 1996; 13(1):55-60. PubMed ID: 8650418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nebulised aerosol size on lung deposition in patients with mild asthma.
    Clay MM; Clarke SW
    Thorax; 1987 Mar; 42(3):190-4. PubMed ID: 3303427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A widely available method for the assessment of aerosol delivery in cystic fibrosis.
    Kastelik JA; Wright GA; Aziz I; Davies M; Avery GR; Paddon AJ; Howey S; Morice AH
    Pulm Pharmacol Ther; 2002; 15(6):513-9. PubMed ID: 12493338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a spacer on pulmonary aerosol deposition from a jet nebuliser during mechanical ventilation.
    Harvey CJ; O'Doherty MJ; Page CJ; Thomas SH; Nunan TO; Treacher DF
    Thorax; 1995 Jan; 50(1):50-3. PubMed ID: 7886649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crossover Evaluation of Compressors and Nebulizers Typically Used by Cystic Fibrosis Patients.
    Awad SM; Berlinski A
    Respir Care; 2018 Mar; 63(3):294-300. PubMed ID: 29432139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosol deposition in infants with cystic fibrosis.
    Mallol J; Rattray S; Walker G; Cook D; Robertson CF
    Pediatr Pulmonol; 1996 May; 21(5):276-81. PubMed ID: 8726152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of jet nebulisers for use with gentamicin solution.
    Newman SP; Pellow PG; Clay MM; Clarke SW
    Thorax; 1985 Sep; 40(9):671-6. PubMed ID: 4060108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled inhalation improves central and peripheral deposition in cystic fibrosis patients with moderate lung disease.
    Bourke C; Devadason S; Ditcham W; Depiazzi J; Everard ML
    J Paediatr Child Health; 2022 Jun; 58(6):1066-1068. PubMed ID: 35174574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The choice of a compressor for the aerosolisation of tobramycin (TOBI) with the PARI LC PLUS reusable nebuliser.
    de Boer AH; Hagedoorn P; Frijlink HW
    Int J Pharm; 2003 Dec; 268(1-2):59-69. PubMed ID: 14643977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung Deposition of Alpha1-Proteinase Inhibitor (Human) (A1-PI[H]) Inhalation Solution Using Two Inhalation Modes of the I-neb Adaptive Aerosol Delivery (AAD) System in Healthy Subjects and Subjects with Cystic Fibrosis.
    Häussermann S; Winnips C; Edelman J; Kappeler D; Herpich C; Ehlich H; Zanker D; Kietzig C; Sommerer K
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):242-50. PubMed ID: 26669827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of two commercial jet nebulisers and three compressors for the nebulisation of antibiotics.
    Hung JC; Hambleton G; Super M
    Arch Dis Child; 1994 Oct; 71(4):335-8. PubMed ID: 7979528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of nebulised antibiotic delivery in cystic fibrosis.
    Wilson D; Burniston M; Moya E; Parkin A; Smye S; Robinson P; Littlewood J
    Arch Dis Child; 1999 Apr; 80(4):348-52. PubMed ID: 10086942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive expiratory pressure changes aerosol distribution in patients with cystic fibrosis.
    Laube BL; Geller DE; Lin TC; Dalby RN; Diener-West M; Zeitlin PL
    Respir Care; 2005 Nov; 50(11):1438-44. PubMed ID: 16253150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosol deposition in equine lungs following ultrasonic nebulisation versus jet aerosol delivery system.
    Votion D; Ghafir Y; Munsters K; Duvivier DH; Art T; Lekeux P
    Equine Vet J; 1997 Sep; 29(5):388-93. PubMed ID: 9306067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary deposition of nebulised amiloride in cystic fibrosis: comparison of two nebulisers.
    Thomas SH; O'Doherty MJ; Graham A; Page CJ; Blower P; Geddes DM; Nunan TO
    Thorax; 1991 Oct; 46(10):717-21. PubMed ID: 1750018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting aerosol deposition in patients with cystic fibrosis: effects of alterations in particle size and inspiratory flow rate.
    Laube BL; Jashnani R; Dalby RN; Zeitlin PL
    Chest; 2000 Oct; 118(4):1069-76. PubMed ID: 11035679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of breathing pattern on lung deposition and bronchodilator response to nebulised salbutamol in patients with stable asthma.
    Zainudin BM; Tolfree SE; Short M; Spiro SG
    Thorax; 1988 Dec; 43(12):987-91. PubMed ID: 3238642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.